Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar Bioyou (< 20) Submitted: 9/30/2011 12:33:31 PM : Outperform Start Price: $9.32 DNDN Score: -38.79

NO.......

Featured Broker Partners


Advertisement